AN EXPERIMENTAL EVALUATION AND COMPARISON OF ANTIEPILEPTIC ACTIVITY OF GANAXOLONE AND ITS COMBINATION WITH SODIUM VALPROATE IN RATS Authors: Seshla S , SUJATA A. JADHAV, CHITRA C. KHANWELKAR, VANDANA M. THORAT AND PRATIBHA S. SALVE
ABSTRACT
Rationale: The positive allosteric modulation of the GABAA receptor complex by neurosteroids
may be an important new approach for antiepileptic interventions. Ganaxolone (GNX) is the first
synthetic analogue of Allopregnanolone, an endogenous neurosteroid.
Objective: To evaluate and compare the antiepileptic effect of GNX with sodium valproate (SV)
and the combined antiepileptic effect of GNX in combination with SV on two seizure models in
male albino wistar rats
Methods: A total of 60 rats were divided into 5 groups, each containing 6 rats for each seizure
model. Group 1 was treated with 40% Hydroxypropyl-?-Cyclodextrin i.p, group 2,3 received
GNX 5mg/kg and 10mg/kg i.p respectively, group 4 received SV 200 mg/kg i.p. and group 5 was
given GNX 5 mg/kg and SV 100 mg/kg i.p. The ability to abolish the Tonic Hind Limb
Extension component was selected as the anticonvulsant activity criteria in the Maximal
Electroshock (MES) induced model. The latency period and duration of seizures were studied in
the pentylenetetrazol (PTZ) induced model.
Results: Our study revealed that GNX (10 mg/kg) and combination of GNX 5 mg/kg with SV
100 mg/kg has promising antiepileptic effect in both the models. The combination of SV and
GNX is additive, but not synergistic or supra-additive.
Conclusions: The results of our study calls for future experiments to assess the therapeutic effect
of GNX and its combination with available antiepileptic drugs and compare it for mono or
polytherapy, based on the balance of adverse effects and efficacy.
Keywords: Ganaxolone, Neurosteroids, Sodium valproate, PTZ, MES Publication date: 01/07/2020 https://ijbpas.com/pdf/2020/July/MS_IJBPAS_2020_5098.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2020/9.7.5098